Skip to main content
TipRanks
Go Ultimate75% OFF

Avenue Therapeutics (49Y) Q3 2018 Earnings Report

1 Followers

DE:49Y Q3 2018 EPS Results

Actual EPS
-EUR 3.30
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
-EUR 3.96

DE:49Y Q3 2018 Revenue Results

Actual Revenue
EUR 0
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q3 2018
Date
11/14/2018
Time
TBA
Conference Call
Wednesday, November 14, 2018

Q3 2018 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q3 2018 Earnings Slide Deck

No slide deck is available for this earnings event.

Q3 2018 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:49Y Earnings History

DE:49Y earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Nov 17, 20252025 (Q3)―-0.19-1.6988.85% (+1.50)
Aug 18, 20252025 (Q2)―0.09-5.65101.63% (+5.75)
May 19, 20252025 (Q1)―-0.55-13.5495.95% (+12.99)
Mar 25, 20252024 (Q4)-0.50-0.6456.05-101.15% (-56.70)
Nov 14, 20242024 (Q3)-0.83-1.693.96-142.67% (-5.64)
Aug 09, 20242024 (Q2)-0.92-5.65-34.2983.51% (+28.64)
May 15, 20242024 (Q1)-7.91-13.54-90.3485.01% (+76.80)
Mar 18, 20242023 (Q4)-6.5956.058.57553.85% (+47.48)
Nov 13, 20232023 (Q3)-17.153.96-29.67113.33% (+33.63)
Aug 10, 20232023 (Q2)-19.12-34.29-27.26-25.79% (-7.03)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed